![Helen Lillistone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Helen Lillistone
Corporate Officer/Principal at
VELOCYS
Profile
Helen Alice Lillistone is currently the Director at Shire Holdings Europe Ltd., Director at NPS Pharma UK Ltd., and Head-Global Finance & Information Technology at Velocys Plc.
Previously, she worked as a Director at Viropharma Ltd. and Head-European Finance Operations at Shire Plc.
She completed her undergraduate degree at Southampton Business School.
Helen Lillistone active positions
| Companies | Position | Start |
|---|---|---|
| VELOCYS | Corporate Officer/Principal | - |
Shire Holdings Europe Ltd.
 Shire Holdings Europe Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Director/Board Member | 2016-03-23 |
NPS Pharma UK Ltd.
 NPS Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Director/Board Member | 2016-03-23 |
Former positions of Helen Lillistone
| Companies | Position | End |
|---|---|---|
Viropharma Ltd.
 Viropharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Board Member | 2018-12-30 |
| SHIRE | Corporate Officer/Principal | - |
Training of Helen Lillistone
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
20
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Velocys Plc
 Velocys Plc Industrial MachineryProducer Manufacturing Designs and develops technology for the production of clean synthetic fuels | Producer Manufacturing |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Shire Holdings Europe Ltd.
Shire Holdings Europe Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Viropharma Ltd.
Viropharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Southampton Business School
 Southampton Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NPS Pharma UK Ltd.
NPS Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
- Stock Market
- Insiders
- Helen Lillistone
